Stock Analiz

Progyny, Inc. (PGNY) financials: revenue, earnings and cash flow

Fiscal 2017–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Progyny’s revenue went from $49M in fiscal 2017 to $1.3B in fiscal 2025, growth of about 50.6% a year.

Net income in fiscal 2025 was $59M, a net margin of 4.5%; the best year in this period was 2021 with $66M.

Over the twelve months to September 30, 2026, revenue was $1.3B and net income $91M.

Free cash flow was $192M in fiscal 2025 and positive in 7 of the 9 years shown.

The diluted share count rose 1483% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2017: $49M172018: $105M182019: $230M192020: $345M202021: $501M212022: $787M222023: $1.1B232024: $1.2B242025: $1.3B25$1.3B
Net income
2017: -$12M172018: $661000182019: -$9M192020: $46M202021: $66M212022: $30M222023: $62M232024: $54M242025: $59M25$59M
Free cash flow
2017: -$10M172018: $2M182019: -$4M192020: $35M202021: $24M212022: $77M222023: $185M232024: $174M242025: $192M25$192M
EPS (diluted)
2017: $-2.37172018: $0.04182019: $-0.41192020: $0.47202021: $0.66212022: $0.30222023: $0.62232024: $0.57242025: $0.6525$0.65

Income statement

Fiscal yearTTM202520242023202220212020201920182017
Revenue$1.3B$1.3B$1.2B$1.1B$787M$501M$345M$230M$105M$49M
Gross profit$333M$304M$253M$239M$167M$112M$70M$46M$19M$7M
Operating income$126M$85M$67M$62M$23M$32M$8M$10M-$3M-$11M
Net income$91M$59M$54M$62M$30M$66M$46M-$9M$661000-$12M
EPS (diluted)$1.09$0.65$0.57$0.62$0.30$0.66$0.47$-0.41$0.04$-2.37
R&D$12M$10M————————
Revenue growth—+10.4%+7.2%+38.3%+57.2%+45.2%+50.1%+117.9%+116.9%—

Cash flow

Fiscal yearTTM202520242023202220212020201920182017
Operating cash flow$207M$210M$179M$189M$80M$26M$36M-$2M$2M-$9M
Capital spending-$28M-$18M-$5M-$4M-$3M-$2M-$1M-$3M-$579000-$612000
Free cash flow$180M$192M$174M$185M$77M$24M$35M-$4M$2M-$10M
Dividends paid—$0$0$0$0$0$0$0$0$0
Buybacks$313M$82M$300M$0$0——$185000$1M—
Stock-based pay$96M$132M$128M$123M$101M$34M$13M$5M$3M$2M

Balance sheet

Fiscal yearTTM202520242023202220212020201920182017
Cash—$310M$228M$371M$189M$119M$109M$80M$127000—
Debt—$28M$19M$19M$8M$9M$10M$10M$253000—
Equity—$516M$422M$553M$377M$252M$167M$114M-$95M-$98M
Total assets—$742M$607M$757M$543M$358M$254M$150M$41M—
Shares (diluted)81M90M95M101M100M100M99M21M6M6M

Margins and returns

Fiscal yearTTM202520242023202220212020201920182017
Gross margin24.9%23.6%21.7%21.9%21.3%22.4%20.3%19.8%18.4%15.2%
Operating margin9.4%6.6%5.8%5.7%3.0%6.5%2.4%4.2%-3.3%-22.7%
Net margin6.8%4.5%4.7%5.7%3.9%13.1%13.5%-3.7%0.6%-25.6%
FCF margin13.4%14.9%14.9%17.0%9.8%4.8%10.2%-1.9%1.6%-20.8%
ROIC—9.6%10.0%9.5%4.8%9.8%3.7%6.2%——
ROE—11.3%12.9%11.2%8.1%26.1%27.8%-7.5%-0.7%12.8%

Frequently asked questions

What is Progyny’s annual revenue?

$1.3B in fiscal 2025 and $1.3B over the twelve months to September 30, 2026.

How much profit does Progyny make?

Net income was $59M in fiscal 2025 (net margin 4.5%).

Is Progyny’s revenue growing?

Yes: revenue rose 10.4% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.